title: Direct transcriptional repression by pRB and its reversal by specific cyclins.
abstract: It was recently shown that the E2F-pRB complex is a negative transcriptional regulator. However, it was not determined whether the whole complex or pRB alone is required for repression. Here we show that pRB and the related protein p107 are capable of direct transcriptional repression independent of E2F. When fused to the DNA binding domain of GAL4, pRB or p107 represses transcription of promoters with GAL4 binding sites. Thus, E2F acts as a tether for pRB or p107 but is not actively involved in repression of other enhancers. This function of pRB maps to the pocket and is abrogated by mutation of this domain. This result suggests an intriguing model in which the pocket has a dual function, first to bind E2F and second to repress transcription directly, possibly through interaction with other proteins. We also show that direct transcriptional repression by pRB is regulated by phosphorylation. Mutations which render pRB constitutively hypophosphorylated potentiate repression, while phosphorylation induced by cyclin A or E reduces repression ninefold.
authors.affiliation: Division of Immunology and Cancer Research, Hospital for Sick Children, Toronto, Canada.
authors.forename: R
authors.initials: R
authors.lastname: Bremner
authors.forename: B L
authors.initials: BL
authors.lastname: Cohen
authors.forename: M
authors.initials: M
authors.lastname: Sopta
authors.forename: P A
authors.initials: PA
authors.lastname: Hamel
authors.forename: C J
authors.initials: CJ
authors.lastname: Ingles
authors.forename: B L
authors.initials: BL
authors.lastname: Gallie
authors.forename: R A
authors.initials: RA
authors.lastname: Phillips
mesh_terms: D001483:Base Sequence; D002460:Cell Line; D016213:Cyclins / Q000378:metabolism* / Q000494:pharmacology; D015972:Gene Expression Regulation, Neoplastic; D016161:Genes, Retinoblastoma / Q000235:genetics*; D006801:Humans; D008969:Molecular Sequence Data; D011993:Recombinant Fusion Proteins / Q000378:metabolism; D016160:Retinoblastoma Protein / Q000378:metabolism* / Q000494:pharmacology; D014158:Transcription, Genetic / Q000187:drug effects*
chemical_list: D016213:Cyclins; D011993:Recombinant Fusion Proteins; D016160:Retinoblastoma Protein